Human endogenous retrovirus-H long terminal repeat-associating 2: an emerging immune checkpoint for cancer immunotherapy.
Saved in:
| Title: | Human endogenous retrovirus-H long terminal repeat-associating 2: an emerging immune checkpoint for cancer immunotherapy. |
|---|---|
| Authors: | Cao Z; Department of Biosciences, Adlai Nortye Biopharma Co., Ltd., No. 1008 Xiangwang Street, Hangzhou 311121, Zhejiang, China., Wang Y; Department of Biosciences, Adlai Nortye Biopharma Co., Ltd., No. 1008 Xiangwang Street, Hangzhou 311121, Zhejiang, China.; State Key Laboratory of Cellular Stress Biology, School of Life Science, Faculty of Medicine and Life Sciences, Xiamen University, No. 422 Siming South Road, Xiamen 361102, Fujian, China., Cheng SC; State Key Laboratory of Cellular Stress Biology, School of Life Science, Faculty of Medicine and Life Sciences, Xiamen University, No. 422 Siming South Road, Xiamen 361102, Fujian, China., He N; Department of Biosciences, Adlai Nortye Biopharma Co., Ltd., No. 1008 Xiangwang Street, Hangzhou 311121, Zhejiang, China. |
| Source: | Journal of leukocyte biology [J Leukoc Biol] 2025 Feb 13; Vol. 117 (2). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8405628 Publication Model: Print Cited Medium: Internet ISSN: 1938-3673 (Electronic) Linking ISSN: 07415400 NLM ISO Abbreviation: J Leukoc Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
